Parksepp, M.; Haring, L.; Kilk, K.; Koch, K.; Uppin, K.; Kangro, R.; Zilmer, M.; Vasar, E.
The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study. Biomedicines 2022, 10, 243.
https://doi.org/10.3390/biomedicines10020243
AMA Style
Parksepp M, Haring L, Kilk K, Koch K, Uppin K, Kangro R, Zilmer M, Vasar E.
The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study. Biomedicines. 2022; 10(2):243.
https://doi.org/10.3390/biomedicines10020243
Chicago/Turabian Style
Parksepp, Madis, Liina Haring, Kalle Kilk, Kadri Koch, Kärt Uppin, Raul Kangro, Mihkel Zilmer, and Eero Vasar.
2022. "The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study" Biomedicines 10, no. 2: 243.
https://doi.org/10.3390/biomedicines10020243
APA Style
Parksepp, M., Haring, L., Kilk, K., Koch, K., Uppin, K., Kangro, R., Zilmer, M., & Vasar, E.
(2022). The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study. Biomedicines, 10(2), 243.
https://doi.org/10.3390/biomedicines10020243